Rogerio Bontorin has been given a three-month U.S. Anti-Doping Agency sanction following a long appeal process that greatly shortened his sentence.
Bontorin tested positive for hydrochlorothiazide as part of an out-of-competition test in early May, per a press release sent out by USADA on Wednesday.
Bontorin’s suspension, which could have been up to two years, was shortened due to the appeal process he engaged in. Bontorin was able to prove that hydrochlorothiazide was in a supplement he was taking despite that supplement being approved by the program.
The appeal process made USADA determine that Bontorin was eligible for a shortened sentence due to the circumstances of his positive test for the diuretic.
“Compounded medications and supplements are more likely to be contaminated because they are mixed by hand, and there is limited regulatory oversight,” said USADA in a statement.
The suspension started in May, meaning it has already expired and Bontorin is eligible to compete again.
Bontorin went public about his positive test in June, revealing that he planned to appeal the suspension.
He has been part of the UFC roster in 2019 and has a promotional record of three wins and two losses.